BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11276365)

  • 1. MGMT expression in murine bone marrow is a major determinant of animal survival after alkylating agent exposure.
    Reese JS; Qin X; Ballas CB; Sekiguchi M; Gerson SL
    J Hematother Stem Cell Res; 2001 Feb; 10(1):115-23. PubMed ID: 11276365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.
    Allay E; Veigl M; Gerson SL
    Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow-derived cells exhibiting lung epithelial cell characteristics are enriched in vivo using methylguanine DNA methyltransferase-mediated drug resistance.
    Reese JS; Roth JC; Gerson SL
    Stem Cells; 2008 Mar; 26(3):675-81. PubMed ID: 18192231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice.
    Reese JS; Allay E; Gerson SL
    Oncogene; 2001 Aug; 20(38):5258-63. PubMed ID: 11536039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells.
    Jansen M; Sorg UR; Ragg S; Flasshove M; Seeber S; Williams DA; Moritz T
    Cancer Gene Ther; 2002 Sep; 9(9):737-46. PubMed ID: 12189523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of MGMT and MLH1 proteins in alkylation-induced apoptosis and mutagenesis.
    Takagi Y; Takahashi M; Sanada M; Ito R; Yamaizumi M; Sekiguchi M
    DNA Repair (Amst); 2003 Oct; 2(10):1135-46. PubMed ID: 13679151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human alkyltransferase-transduced murine myeloid progenitors are enriched in vivo by BCNU treatment of transplanted mice.
    Allay JA; Davis BM; Gerson SL
    Exp Hematol; 1997 Sep; 25(10):1069-76. PubMed ID: 9293904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents.
    Glassner BJ; Weeda G; Allan JM; Broekhof JL; Carls NH; Donker I; Engelward BP; Hampson RJ; Hersmus R; Hickman MJ; Roth RB; Warren HB; Wu MM; Hoeijmakers JH; Samson LD
    Mutagenesis; 1999 May; 14(3):339-47. PubMed ID: 10375003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo.
    Moritz T; Mackay W; Glassner BJ; Williams DA; Samson L
    Cancer Res; 1995 Jun; 55(12):2608-14. PubMed ID: 7780976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
    Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
    Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced severe immunodeficiency by transduction of murine long-lived hemopoietic progenitor cells using O6-methylguanine DNA methyltransferase complementary DNA.
    Maze R; Kapur R; Kelley MR; Hansen WK; Oh SY; Williams DA
    J Immunol; 1997 Jan; 158(2):1006-13. PubMed ID: 8993023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid repair of O6-methylguanine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomas.
    Liu L; Allay E; Dumenco LL; Gerson SL
    Cancer Res; 1994 Sep; 54(17):4648-52. PubMed ID: 8062258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents.
    Bearzatto A; Szadkowski M; Macpherson P; Jiricny J; Karran P
    Cancer Res; 2000 Jun; 60(12):3262-70. PubMed ID: 10866320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of a P140K mutant O6-methylguanine-DNA-methyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow.
    Kramer BA; Lemckert FA; Alexander IE; Gunning PW; McCowage GB
    J Gene Med; 2006 Sep; 8(9):1071-85. PubMed ID: 16927363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent.
    Maze R; Carney JP; Kelley MR; Glassner BJ; Williams DA; Samson L
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):206-10. PubMed ID: 8552605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repair of O6-alkylguanine during DNA synthesis in murine bone marrow hematopoietic precursors.
    Gerson SL; Trey JE; Miller K; Benjamin E
    Cancer Res; 1987 Jan; 47(1):89-95. PubMed ID: 3539320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug selection of mutant methylguanine methyltransferase from different oncoretroviral backbones results in multilineage hematopoietic transgene expression in primary and secondary recipients.
    Davis BM; Reese JS; Lingas K; Gerson SL
    J Hematother Stem Cell Res; 2003 Aug; 12(4):375-87. PubMed ID: 12965075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal inventory screens uncover monoclonality following serial transplantation of MGMT P140K-transduced stem cells and dose-intense chemotherapy.
    Giordano FA; Sorg UR; Appelt JU; Lachmann N; Bleier S; Roeder I; Kleff V; Flasshove M; Zeller WJ; Allgayer H; von Kalle C; Fruehauf S; Moritz T; Laufs S
    Hum Gene Ther; 2011 Jun; 22(6):697-710. PubMed ID: 21319998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice.
    Kawate H; Itoh R; Sakumi K; Nakabeppu Y; Tsuzuki T; Ide F; Ishikawa T; Noda T; Nawata H; Sekiguchi M
    Carcinogenesis; 2000 Feb; 21(2):301-5. PubMed ID: 10657972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis.
    Qin X; Zhou H; Liu L; Gerson SL
    Carcinogenesis; 1999 Sep; 20(9):1667-73. PubMed ID: 10469609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.